PURE Bioscience financial statements
PURE Bioscience's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2026
| Revenue | USD 2.31M | 10-K |
| Net income | −USD 2.48M | 10-K |
| Cash and equivalents | USD 569K | 10-K |
| Total debt | USD 6.6M | 10-K |